drugset / Trial / NCT01777620

A Study of Subject Satisfaction With BOTOX® Cosmetic Treatment in Facial Rhytides

NCT01777620

Phase 4 Completed 125 enrolled Allergan
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a safety and efficacy study of BOTOX® in subjects with facial rhytides (glabellar lines and crow's feet lines).

Timeline

Start
2013-01-31
Primary completion
2013-05-29
Completion
2013-07-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin type A Protein / enzyme biologic

Indications

No indication recorded.